Product Images Lenalidomide

Not-Available. The given text contains errors where some words and numbers are not readable and cannot be used to generate a useful description.*

DrReddys' Lenalidomide capsules of 25mg strength with the NDC code 43598-51521 have the potential to cause birth defects in humans and comes in a package of 21 capsules. Other unclear characters and symbols are present in the text.*

This is a clinical trial result. It includes the proportion of subjects who underwent treatment with Lenalidomide/Dex and Placebo/Dex. The results show the hazard ratio (HR) and the 95% confidence interval (CI) for time to progression (months) using Log Rank analysis. The HR for the Lenalidomide/Dex group was 0.285 (95% CI: 0.210-0.386) with a statistically significant p-value of less than 0.001. The time to progression graph is also provided.*

The text describes the results of a study comparing treatment with Lenalidomide/Dex versus Placebo/Dex. The proportion of subjects in each group is unclear. The study found that Lenalidomide/Dex significantly increased time to progression compared to Placebo/Dex. The hazard ratio for Lenalidomide/Dex vs Placebo/Dex is 0.324 with 95% confidence interval (0.240-0.438). The p-value for the difference between the two groups is less than 0.001. Time to progression is plotted over 25 months.*

This text presents statistical data from a study comparing the survival probability of patients treated with Lenalidomide or placebo. The results show that Lenalidomide has a significantly higher survival rate. The text also includes a graph showing the progression-free survival in months and the number of subjects at risk.*